… Crohns disease patients, who failed anti-TNF treatment and started vedolizumab or … ,
were identified in the observational prospective Dutch Initiative on Crohn and Colitis Registry. …

… Dutch national reference standards for all patients included in the Netherlands and the WHO
growth reference standards … after infliximab withdrawal for patients with Crohn's disease in …

… in patients with Crohn's disease (CD). We investigated pharmacodynamic features of infliximab
and … The multicenter (27 centers in Belgium, France, and the Netherlands) randomized …

… patients who received short-term anti-TNF treatment and surgical closure compared with those
who received anti-TNF treatment alone. … in the Netherlands and one hospital in Italy. Adult …

… empirically escalating anti-TNF dose or switching therapies. … of 25 paediatric inflammatory
bowel disease [IBD] experts who … Additionally, a Dutch cohort of new-onset CD showed that …

… the CEASE project, based on patients from Dutch hospitals. We externally … Inflammatory
Bowel Disease guidelines which state that anti-TNF cessation is recommended only in patients …

… in the Netherlands in 2014… anti-TNF exposed patients with IBD treated with vedolizumab
were in corticosteroid-free clinical remission after 2 years. Fifty-nine percent of patients with IBD …

… the Dutch Initiative on Crohn and Colitis [ICC] Registry: a nationwide registry for inflammatory
bowel disease [IBD] patients … of ustekinumab treatment [anti-TNF exposed 65.2%, anti-TNF/…

… who participated in this study and all the research teams at the participating centres within
the Netherlands. Figures in the graphical abstract were based on: Clock icon created by …

… anti-TNF therapy after resection of the affected bowel region in previously anti-TNF refractory
adult Crohn’s disease patients is … anti-TNF therapy for postoperative recurrence in Crohn’s …